Last updated: 11/07/2018 18:11:43
Open label pilot study to evaluate the effect of antiretroviral drugs on HIV-1 in different compartments (plasma and lymphoid tissues).
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Open label pilot study to evaluate the effect of antiretroviral drugs on HIV-1 in different compartments (plasma and lymphoid tissues).
Trial description: Open label pilot study to evaluate the effect of antiretroviral drugs on HIV-1 in different compartments (plasma and lymphoid tissues).
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
P. Racz, C. Tenner-Racz, D. Praindhui, A. Goetschel; G. Carcelain; N. Delphin et al. Virus burden, immunoarchitectural changes in lymphoid tissues in HIV-1 infected patients (PTS) treated 18 months with HAART with or without PI: PROF3002 ATTILA . 2nd IAS Conference on HIV Pathogenesis and treatment, Paris, France, July 13-16, 2003. Antiviral Therapy 2003; 8 (SUPPL1): S296 - Abstract 429.
Medical condition
Infection, Human Immunodeficiency Virus
Product
amprenavir
Collaborators
Not applicable
Study date(s)
February 1998 to March 2002
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2002-01-03
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website